Sepsis is a life-threatening condition that reportedly affects more than 30 million people worldwide each year. Early identification of the causative pathogen significantly improves patient outcomes in terms of morbidity and mortality, and has a positive impact on the healthcare economy. Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) is capable of reducing turnaround times by up to 48 hours compared to standard laboratory protocols.